Clinical Challenge: Solitary Lesion on Hand

Slideshow

  • Slide

A 44-year-old man presents requesting removal of a growth on his right hand. The lesion has been present for at least 6 months and was treated elsewhere with 2 courses of liquid nitrogen, which proved ineffectual. The patient has no pain at the site unless traumatized. He is in good health and denies history of systemic disease. Examination reveals a firm, fixed 1.8cm slightly pinkish nodule with a hyperpigmented rim. No similar lesions are noted elsewhere.

Cutaneous focal mucinosis is a skin condition characterized by mucin accumulation primarily in the dermis. Johnson and Helwig first described mucinosis as a solitary lesion in 1966.1 To differentiate these patients from those with multiple lesions, Kuo et al suggested the...

Submit your diagnosis to see full explanation.

Cutaneous focal mucinosis is a skin condition characterized by mucin accumulation primarily in the dermis. Johnson and Helwig first described mucinosis as a solitary lesion in 1966.1 To differentiate these patients from those with multiple lesions, Kuo et al suggested the name solitary cutaneous focal mucinosis.2 Cutaneous focal mucinosis are classified as either primary or secondary, with mucin deposition in the latter associated with an underlying condition.3,4

Solitary lesions in cutaneous focal mucinosis typically present as flesh-colored to white or red, asymptomatic, dome-shaped papules. Lesions appear most commonly on the arms but have been reported on legs, head, neck, and trunk.3,4 There is a slight male predilection with age of presentation ranging from 29 to 60 years. Clinical differential diagnosis is broad and includes dermatofibroma, neurofibroma, basal cell carcinoma, epidermoid inclusion cysts, seborrheic keratoses, and others.3-5

As noted, multiple cutaneous focal mucinoses are associated with systemic diseases. These include scleroderma, scleromyxedema, Birt-Hogg-Dube syndrome, thyroid disease, and systemic lupus erythematous.5-7 A detailed family history and laboratory evaluation are merited in these patients, including thyroid stimulating hormone (TSH), thyroid anti-bodies, serum protein electrophoresis, antinuclear antibody, dsDNA, Smith antibody, and scleroderma 70 antibody.5-7

Because of the variable morphologic presentation, biopsy of cutaneous focal mucinosis is necessary to establish the diagnosis.3-5 Hematoxylin and eosin-staining will demonstrate unencapsulated mucin in the upper dermis associated with scattered fibroblasts. Mucin specific stains are useful to confirm the diagnosis.3 Simple local excision of the lesion is the treatment of choice and has a low recurrence rate.

Alexandra Stroia, DO,  is a PGY-1 Transitional Year Resident at Geisinger Community Medical Center, in Scranton, Pennsylvania. Stephen Schleicher, MD, is director of the DermDox Dermatology Centers, associate professor of medicine at Geisinger Commonwealth Medical College, and clinical instructor of dermatology at Arcadia University and Kings College.

References

1. Johnson WC, Helwig EB. Cutaneous focal mucinosis. A clinicopathological and histochemical studyArch Dermatol. 1966;93(1):13-20. doi:10.1001/archderm.1966.0160019001900

2. Kuo KL, Lee LY, Kuo TT. Solitary cutaneous focal mucinosis: a clinicopathological study of 11 cases of soft fibroma-like cutaneous mucinous lesionsJ Dermatol. 2017;44(3):335-338. doi:10.1111/1346-8138.13523

3. Rongioletti F, Rebora A. Les mucinoses cutanées [Cutaneous mucinosis]. Ann Dermatol Venereol. 1993;120(1):75-87.

4. Gutierrez N, Erickson C, Calame A, Cohen PR. Solitary cutaneous focal mucinosisCureus. 2021;13(10):e18618. doi:10.7759/cureus.18618

5. Cohen PR, Erickson CP, Calame A. Case report and review of solitary cutaneous focal mucinosis: a unique primary cutaneous mucinosis unrelated to mucinosis-associated systemic diseasesDermatol Online J. 2020;26(8):13030/qt33m815p3. doi:10.5070/D3268049883

6. Jakubovic HR, Salama SS, Rosenthal D. Multiple cutaneous focal mucinoses with hypothyroidismAnn Intern Med. 1982;96(1):56-58. doi:10.7326/0003-4819-96-1-56

7. Baxi KD, Chaudhary RG, Rathod SP, Jagati A. Monoclonal gammopathy of undetermined significance-associated scleromyxoedemaIndian Dermatol Online J. 2019;10(1):54-57. doi:10.4103/idoj.IDOJ_138_18